We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · October 06, 2021

Secukinumab's Effect on Structural Damage Progression in Psoriatic Arthritis

Clinical and Experimental Rheumatology

 

Additional Info

Clinical and Experimental Rheumatology
Secukinumab's effect on structural damage progression in psoriatic arthritis: longitudinal mixture modelling of FUTURE-1 and FUTURE-5
Clin. Exp. Rheumatol. 2021 Aug 31;39(5)931-937, O Luttringer, T Fox, L Pricop, C Gaillez, H Karcher, W Wiecek, Z Angehrn, B Amzal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading